Novel Interventions for the Diverse Population of Australians with Bronchiectasis [ 2010 - 2017 ]

Research Grant

Researchers: Prof Peter Bye (Principal investigator) ,  A/Pr Joseph Mccormack ,  Dr Mark Elkins ,  Prof Paul Torzillo ,  Prof Peter Wark
View all 6 related researchers

Brief description Bronchiectasis is a chronic lung condition in which infection causes wheeze, breathlessness, fatigue and sputum production - markedly reducing quality of life and requiring repeated hospital admissions. Risk of hospitalisation due to the disease is up to 9-fold higher in Indigenous vs other Australians. This research will examine two new, low-cost therapies with excellent potential to treat bronchiectasis: a new antibiotic, Azithromycin, and a mucus-clearance agent, hypertonic saline.

Funding Amount $AUD 726,822.90

Funding Scheme Project Grants

Notes Standard Project Grant